These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Inherited epidermolysis bullosa: past, present, and future. Fine JD Ann N Y Acad Sci; 2010 Apr; 1194():213-22. PubMed ID: 20536471 [TBL] [Abstract][Full Text] [Related]
7. Treatment of hereditary epidermolysis bullosa: updates and future prospects. Hsu CK; Wang SP; Lee JY; McGrath JA Am J Clin Dermatol; 2014 Feb; 15(1):1-6. PubMed ID: 24402870 [TBL] [Abstract][Full Text] [Related]
9. Advances in Treatments for Epidermolysis Bullosa (EB): Emphasis on Stem Cell-Based Therapy. Raoufinia R; Rahimi HR; Keyhanvar N; Moghbeli M; Abdyazdani N; Rostami M; Naghipoor K; Forouzanfar F; Foroudi S; Saburi E Stem Cell Rev Rep; 2024 Jul; 20(5):1200-1212. PubMed ID: 38430362 [TBL] [Abstract][Full Text] [Related]
10. Disorders of the cutaneous basement membrane zone--the paradigm of epidermolysis bullosa. Bruckner-Tuderman L; Has C Matrix Biol; 2014 Jan; 33():29-34. PubMed ID: 23917088 [TBL] [Abstract][Full Text] [Related]
11. Epidermolysis bullosa: from fundamental molecular biology to clinical therapies. Featherstone C J Invest Dermatol; 2007 Feb; 127(2):256-9. PubMed ID: 17228301 [No Abstract] [Full Text] [Related]
12. Thymosin β4: potential to treat epidermolysis bullosa and other severe dermal injuries. Yang WS; Kang S; Sung J; Kleinman HK Eur J Dermatol; 2019 Oct; 29(5):459-467. PubMed ID: 31649007 [TBL] [Abstract][Full Text] [Related]
13. EB2017-Progress in Epidermolysis Bullosa Research toward Treatment and Cure. Uitto J; Bruckner-Tuderman L; McGrath JA; Riedl R; Robinson C J Invest Dermatol; 2018 May; 138(5):1010-1016. PubMed ID: 29391251 [TBL] [Abstract][Full Text] [Related]
14. Therapies for genetic extracellular matrix diseases of the skin. Nyström A; Bernasconi R; Bornert O Matrix Biol; 2018 Oct; 71-72():330-347. PubMed ID: 29274938 [TBL] [Abstract][Full Text] [Related]